Search
for
Sort by
Research 91–120 of 1000+
- Double-Blind, Placebo-Controlled Pilot Study on the Use of Platelet-Rich Plasma in Women With Female Androgenetic Alopecia
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase 1/2 inhibitor, in adults with alopecia areata: Results from the THRIVE-AA2 Phase 3, randomized, double-blind, controlled trial
- Combined Oral Contraception and Bicalutamide in Polycystic Ovary Syndrome and Severe Hirsutism: A Double-Blind Randomized Controlled Trial
- Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial
- No significant impact of platelet‐rich plasma on recovery after Achilles tendon surgery: A double‐blind randomized controlled trial
- Safety and efficacy of ALRV5XR in women with androgenetic alopecia or telogen effluvium: A randomised, double-blinded, placebo-controlled clinical trial
- Saw Palmetto
- A Study on the Effectiveness and Safety of Herbal Extract Combination Compared to 3% Minoxidil Solution for the Treatment of Androgenetic Alopecia: A Randomized, Double-blind, Controlled Trial
- Proxalutamide (GT0918) Reduces the Rate of Hospitalization in mild-to-moderate COVID-19 Female Patients: A Randomized Double-Blinded Placebo-Controlled Two-Arm Parallel Trial
- Faculty Opinions recommendation of Low-level light therapy for androgenetic alopecia: a 24-week, randomized, double-blind, sham device-controlled multicenter trial.
- Topical Valproate Solution for Hair Growth
- A randomized double blind study of the effect of finasteride on hair growth in male patients of androgenetic alopecia
- Bicalutamide 25 mg associated with minoxidil 1 mg versus minoxidil 1 mg for female-pattern hair loss: A randomized double-blind clinical trial
- LB1773 Dutasteride in the treatment of frontal fibrosing alopecia: Systematic review and meta-analysis
- Hair Growth-Promoting Effects of a Multi-Targeted Cosmetic Formulation Containing PYGL, DP2, and 15-PGDH Inhibitors Developed Using AI-Based DeepZema® in Androgenetic Alopecia: A 24-Week Randomized Controlled Trial
- Introduction and Summary of Findings
- The potential use of phenolic compounds in the treatment of hair loss: a literature review
- A 2% Oleosome-FGF-2 Fusion Extract Scalp Serum Improves Photo-trichogramDerived Hair Density, Anagen/Telogen Ratio, Hair Shaft Thickness, and Scalp Barrier Parameters in Women with Shedding-Prone Hair: A Randomized, SingleBlind, Placebo-Controlled Pilot Study
- Use and Misuse of PRP: Clinical Trial Proposal to Help Find PRP’s True Efficacy
- Is Minoxidil Efficacious and Safe for the Treatment of Androgenetic Alopecia (AGA) in Men, and If So, What Is the Optimal Strength and Means of Delivery?
- Frontal fibrosing alopecia and lichen planus pigmentosus
- Finasteride reduces serum PSA to a similar extent at 1 mg and 5 mg daily doses
- Platelet-Rich Plasma for Urologic Conditions: An Early Call for Composition Reporting
- Value of Nutrition-Based Therapies for Hair Growth, Color, and Quality
- 5‐alpha‐reductase inhibitor treatment for frontal fibrosing alopecia: an evidence‐based treatment update
- Saw palmetto and finasteride in the treatment of category-iii prostatitis/chronic pelvic pain syndrome
- Тіе Modern treatment of androgenetic alopecia
- Dutasteride in Androgenetic Alopecia: An Update
- Testosterone metabolite nonessential for androgen effects
- A double-blind, placebo-controlled study of inositol in trichotillomania